![FDA, FTC and DOJ Enforcement of Medical Device Regulations FDA, FTC and DOJ Enforcement of Medical Device Regulations](https://www.fdanews.com/ext/resources/Book-Covers-2/BFFDEMDR-COVER.png?height=200&t=1685733565&width=200)
Home » AAIPHARMA ESTABLISHES AAIONCOLOGY BUSINESS UNIT AND EXPANDS GLOBAL CLINICAL DEVELOPMENT OPERATIONS THROUGH ACQUISITION OF CVITKOVIC & ASSOCIES CONSULTANTS S.A.
AAIPHARMA ESTABLISHES AAIONCOLOGY BUSINESS UNIT AND EXPANDS GLOBAL CLINICAL DEVELOPMENT OPERATIONS THROUGH ACQUISITION OF CVITKOVIC & ASSOCIES CONSULTANTS S.A.
AAIPharma Inc. announced a definitive agreement to acquire Cvitkovic & Associes Consultants S.A. (CAC), an international contract research organization specializing in oncology drug development and medical consulting. The acquisition of CAC provides AAIPharma with additional therapeutic expertise, while further strengthening its global clinical development business.
Business Wire (http://home.businesswire.com/portal/site/google/index.jsp?ndmViewId=news_view&newsId=20060919005348&newsLang=en)
KEYWORDS FDAnews Drug Daily Bulletin
Upcoming Events
-
11Jul
-
18Jul
-
21Oct